
Benjamin J. Packard
Examiner (ID: 7369, Phone: (571)270-3440 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1609, 1612, 4173 |
| Total Applications | 1700 |
| Issued Applications | 945 |
| Pending Applications | 209 |
| Abandoned Applications | 578 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19462265
[patent_doc_number] => 20240315934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => Oral Care Compositions
[patent_app_type] => utility
[patent_app_number] => 18/732903
[patent_app_country] => US
[patent_app_date] => 2024-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9141
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18732903
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/732903 | Oral care compositions | Jun 3, 2024 | Issued |
Array
(
[id] => 19462304
[patent_doc_number] => 20240315973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => INDIGENOUS AND IMPROVED BACTERIALLY FERMENTED CBD, CBG AND RELATED CANNABINOID ORAL DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 18/731515
[patent_app_country] => US
[patent_app_date] => 2024-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18731515
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/731515 | INDIGENOUS AND IMPROVED BACTERIALLY FERMENTED CBD, CBG AND RELATED CANNABINOID ORAL DOSAGE FORMS | Jun 2, 2024 | Pending |
Array
(
[id] => 19762195
[patent_doc_number] => 12220466
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-11
[patent_title] => Pharmaceutical formulation
[patent_app_type] => utility
[patent_app_number] => 18/674445
[patent_app_country] => US
[patent_app_date] => 2024-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 33763
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18674445
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/674445 | Pharmaceutical formulation | May 23, 2024 | Issued |
Array
(
[id] => 19599379
[patent_doc_number] => 20240390259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => MASCARA FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/674250
[patent_app_country] => US
[patent_app_date] => 2024-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23278
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18674250
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/674250 | MASCARA FORMULATION | May 23, 2024 | Pending |
Array
(
[id] => 19657110
[patent_doc_number] => 20240424175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => ANTICOAGULANT COMPOUNDS COMPRISING CHELATING AGENTS AND CATIONIC ANTI-COAGULATION ENHANCERS AND METHODS AND DEVICES FOR THEIR USE
[patent_app_type] => utility
[patent_app_number] => 18/672288
[patent_app_country] => US
[patent_app_date] => 2024-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18672288
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/672288 | ANTICOAGULANT COMPOUNDS COMPRISING CHELATING AGENTS AND CATIONIC ANTI-COAGULATION ENHANCERS AND METHODS AND DEVICES FOR THEIR USE | May 22, 2024 | Pending |
Array
(
[id] => 19599393
[patent_doc_number] => 20240390273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => Pharmaceutical Composition for Dry Powder Inhalation and Preparation Method Thereof
[patent_app_type] => utility
[patent_app_number] => 18/671722
[patent_app_country] => US
[patent_app_date] => 2024-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18671722
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/671722 | Pharmaceutical Composition for Dry Powder Inhalation and Preparation Method Thereof | May 21, 2024 | Pending |
Array
(
[id] => 19417476
[patent_doc_number] => 20240293599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => BONE-REGENERATION-PROMOTING MATERIAL, AND METHOD FOR PRODUCING BONE-REGENERATION-PROMOTING MATERIAL
[patent_app_type] => utility
[patent_app_number] => 18/663231
[patent_app_country] => US
[patent_app_date] => 2024-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18663231
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/663231 | BONE-REGENERATION-PROMOTING MATERIAL, AND METHOD FOR PRODUCING BONE-REGENERATION-PROMOTING MATERIAL | May 13, 2024 | Pending |
Array
(
[id] => 19650021
[patent_doc_number] => 12171781
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-12-24
[patent_title] => Stable, highly pure L-cysteine compositions for injection and methods of use
[patent_app_type] => utility
[patent_app_number] => 18/651026
[patent_app_country] => US
[patent_app_date] => 2024-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 29075
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18651026
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/651026 | Stable, highly pure L-cysteine compositions for injection and methods of use | Apr 29, 2024 | Issued |
Array
(
[id] => 19674500
[patent_doc_number] => 12186338
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-01-07
[patent_title] => Stable, highly pure L-cysteine compositions for injection and methods of use
[patent_app_type] => utility
[patent_app_number] => 18/651036
[patent_app_country] => US
[patent_app_date] => 2024-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 28955
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18651036
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/651036 | Stable, highly pure L-cysteine compositions for injection and methods of use | Apr 29, 2024 | Issued |
Array
(
[id] => 19554690
[patent_doc_number] => 20240366482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => STABLE BIOACTIVE GLASS FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/642098
[patent_app_country] => US
[patent_app_date] => 2024-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18642098
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/642098 | STABLE BIOACTIVE GLASS FORMULATIONS | Apr 21, 2024 | Pending |
Array
(
[id] => 19343474
[patent_doc_number] => 20240252437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => Methods For and Products From Encapsulation of Drugs in Nanoparticles in a Microgravity Environment
[patent_app_type] => utility
[patent_app_number] => 18/634819
[patent_app_country] => US
[patent_app_date] => 2024-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18634819
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/634819 | Methods For and Products From Encapsulation of Drugs in Nanoparticles in a Microgravity Environment | Apr 11, 2024 | Pending |
Array
(
[id] => 20293804
[patent_doc_number] => 20250319047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-16
[patent_title] => ANTIMICROBIAL TREATMENT AND PREVENTION BY PERILLYL ALCOHOL AND DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 18/633441
[patent_app_country] => US
[patent_app_date] => 2024-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18633441
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/633441 | ANTIMICROBIAL TREATMENT AND PREVENTION BY PERILLYL ALCOHOL AND DERIVATIVES | Apr 10, 2024 | Pending |
Array
(
[id] => 20048112
[patent_doc_number] => 20250186334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-12
[patent_title] => TOPICAL OCULAR THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/629882
[patent_app_country] => US
[patent_app_date] => 2024-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18629882
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/629882 | TOPICAL OCULAR THERAPY | Apr 7, 2024 | Pending |
Array
(
[id] => 19379871
[patent_doc_number] => 20240269741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => Functional Porous Particles Embedded/Immobilized Within Porous Structures, Formation & Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/625971
[patent_app_country] => US
[patent_app_date] => 2024-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18625971
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/625971 | Functional Porous Particles Embedded/Immobilized Within Porous Structures, Formation & Uses Thereof | Apr 2, 2024 | Abandoned |
Array
(
[id] => 19762212
[patent_doc_number] => 12220483
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-11
[patent_title] => Liposome compositions comprising weak acid drugs and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/608182
[patent_app_country] => US
[patent_app_date] => 2024-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7066
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18608182
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/608182 | Liposome compositions comprising weak acid drugs and uses thereof | Mar 17, 2024 | Issued |
Array
(
[id] => 19279820
[patent_doc_number] => 20240216292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => Trans-Epithelial Membrane Drug Delivery System
[patent_app_type] => utility
[patent_app_number] => 18/604319
[patent_app_country] => US
[patent_app_date] => 2024-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18604319
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/604319 | Trans-epithelial membrane drug delivery system | Mar 12, 2024 | Issued |
| 18/686004 | LYOTROPIC LIQUID CRYSTALLINE NANOSYSTEMS WITH ENCAPSULATED BIOACTIVE MACROMOLECULES | Feb 22, 2024 | Pending |
Array
(
[id] => 19246713
[patent_doc_number] => 20240197697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/435221
[patent_app_country] => US
[patent_app_date] => 2024-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18435221
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/435221 | Rifabutin treatment methods, uses, and compositions | Feb 6, 2024 | Issued |
Array
(
[id] => 19316665
[patent_doc_number] => 20240238205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION
[patent_app_type] => utility
[patent_app_number] => 18/392891
[patent_app_country] => US
[patent_app_date] => 2023-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27130
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -75
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18392891
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/392891 | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation | Dec 20, 2023 | Issued |
Array
(
[id] => 19263452
[patent_doc_number] => 20240207149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => Method For Cleaning Surfaces And Treatment Solution For Same
[patent_app_type] => utility
[patent_app_number] => 18/531322
[patent_app_country] => US
[patent_app_date] => 2023-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18531322
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/531322 | Method For Cleaning Surfaces And Treatment Solution For Same | Dec 5, 2023 | Pending |